(FLS) Flowserve - Ratings and Ratios
Pumps, Seals, Valves, Actuators, Aftermarket
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.17% |
| Yield on Cost 5y | 2.50% |
| Yield CAGR 5y | 1.23% |
| Payout Consistency | 76.3% |
| Payout Ratio | 26.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 26.9% |
| Value at Risk 5%th | 42.6% |
| Relative Tail Risk | -3.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.57 |
| Alpha | 0.00 |
| CAGR/Max DD | 0.84 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.475 |
| Beta | 1.505 |
| Beta Downside | 1.705 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.76% |
| Mean DD | 7.73% |
| Median DD | 4.33% |
Description: FLS Flowserve January 07, 2026
Flowserve Corporation (NYSE:FLS) designs, manufactures, distributes, and services industrial flow-management equipment across North America, Europe, the Middle East, Africa, and the Asia-Pacific. It operates two primary segments: the Flowserve Pump Division (FPD), which supplies custom-engineered and pre-configured pumps, mechanical seals, and aftermarket services, and the Flow Control Division (FCD), which provides isolation and control valves, actuators, positioners, and related field services. The company’s product portfolio is sold under the Valtek, Argus, Worcester, Limitorque, and Durco brands to end-markets that include oil & gas, power generation, chemicals, water management, mining, food & beverage, steel, and pulp & paper.
Key recent metrics: FY 2023 revenue reached $4.3 billion, with an adjusted EBITDA margin of 13.5 % and a free-cash-flow conversion of ≈ 85 %. The order backlog stood at roughly $2.4 billion, indicating a 55 % coverage of FY 2024 earnings, and roughly 30 % of sales are tied to oil-and-gas capital-expenditure cycles, making the segment sensitive to commodity price swings and the broader energy-transition push. A secular driver for Flowserve is the global increase in water-infrastructure spending, projected by the World Bank to exceed $1 trillion by 2030, which underpins demand for pumps and valve solutions in municipal and industrial water-treatment projects.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of Flowserve’s cash-flow dynamics and valuation sensitivities.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (452.8m TTM) > 0 and > 6% of Revenue (6% = 281.2m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 4.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 35.41% (prev 31.47%; Δ 3.95pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 703.4m > Net Income 452.8m (YES >=105%, WARN >=100%) |
| Net Debt (837.3m) to EBITDA (798.0m) ratio: 1.05 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.10 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (131.2m) change vs 12m ago -0.77% (target <= -2.0% for YES) |
| Gross Margin 33.72% (prev 31.50%; Δ 2.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 84.42% (prev 86.12%; Δ -1.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.94 (EBITDA TTM 798.0m / Interest Expense TTM 78.6m) >= 6 (WARN >= 3) |
Altman Z'' 6.32
| (A) 0.28 = (Total Current Assets 3.16b - Total Current Liabilities 1.50b) / Total Assets 5.83b |
| (B) 0.74 = Retained Earnings (Balance) 4.32b / Total Assets 5.83b |
| (C) 0.13 = EBIT TTM 702.9m / Avg Total Assets 5.55b |
| (D) 1.13 = Book Value of Equity 3.95b / Total Liabilities 3.51b |
| Total Rating: 6.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.25
| 1. Piotroski 7.50pt |
| 2. FCF Yield 6.23% |
| 3. FCF Margin 13.42% |
| 4. Debt/Equity 0.74 |
| 5. Debt/Ebitda 1.05 |
| 6. ROIC - WACC (= 3.72)% |
| 7. RoE 21.12% |
| 8. Rev. Trend 88.62% |
| 9. EPS Trend 45.88% |
What is the price of FLS shares?
Over the past week, the price has changed by +3.53%, over one month by +1.03%, over three months by +38.52% and over the past year by +22.70%.
Is FLS a buy, sell or hold?
- Strong Buy: 8
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the FLS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 78.2 | 8.9% |
| Analysts Target Price | 78.2 | 8.9% |
| ValueRay Target Price | 88.4 | 23.1% |
FLS Fundamental Data Overview January 05, 2026
P/E Trailing = 20.5669
P/E Forward = 18.1488
P/S = 1.974
P/B = 3.972
P/EG = 1.8141
Beta = 1.312
Revenue TTM = 4.69b USD
EBIT TTM = 702.9m USD
EBITDA TTM = 798.0m USD
Long Term Debt = 1.44b USD (from longTermDebt, last quarter)
Short Term Debt = 81.4m USD (from shortTermDebt, last quarter)
Debt = 1.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 837.3m USD (from netDebt column, last quarter)
Enterprise Value = 10.09b USD (9.25b + Debt 1.67b - CCE 833.8m)
Interest Coverage Ratio = 8.94 (Ebit TTM 702.9m / Interest Expense TTM 78.6m)
FCF Yield = 6.23% (FCF TTM 629.0m / Enterprise Value 10.09b)
FCF Margin = 13.42% (FCF TTM 629.0m / Revenue TTM 4.69b)
Net Margin = 9.66% (Net Income TTM 452.8m / Revenue TTM 4.69b)
Gross Margin = 33.72% ((Revenue TTM 4.69b - Cost of Revenue TTM 3.11b) / Revenue TTM)
Gross Margin QoQ = 34.55% (prev 34.65%)
Tobins Q-Ratio = 1.73 (Enterprise Value 10.09b / Total Assets 5.83b)
Interest Expense / Debt = 1.12% (Interest Expense 18.7m / Debt 1.67b)
Taxrate = 29.50% (93.7m / 317.5m)
NOPAT = 495.5m (EBIT 702.9m * (1 - 29.50%))
Current Ratio = 2.10 (Total Current Assets 3.16b / Total Current Liabilities 1.50b)
Debt / Equity = 0.74 (Debt 1.67b / totalStockholderEquity, last quarter 2.26b)
Debt / EBITDA = 1.05 (Net Debt 837.3m / EBITDA 798.0m)
Debt / FCF = 1.33 (Net Debt 837.3m / FCF TTM 629.0m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.77% (Net Income 452.8m / Total Assets 5.83b)
RoE = 21.12% (Net Income TTM 452.8m / Total Stockholder Equity 2.14b)
RoCE = 19.64% (EBIT 702.9m / Capital Employed (Equity 2.14b + L.T.Debt 1.44b))
RoIC = 13.63% (NOPAT 495.5m / Invested Capital 3.64b)
WACC = 9.91% (E(9.25b)/V(10.92b) * Re(11.56%) + D(1.67b)/V(10.92b) * Rd(1.12%) * (1-Tc(0.30)))
Discount Rate = 11.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.34%
[DCF Debug] Terminal Value 56.43% ; FCFE base≈517.7m ; Y1≈339.9m ; Y5≈155.4m
Fair Price DCF = 15.09 (DCF Value 1.92b / Shares Outstanding 127.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 45.88 | EPS CAGR: -18.63% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.62 | Revenue CAGR: 6.74% | SUE: -0.88 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.87 | Chg30d=+0.007 | Revisions Net=+2 | Analysts=7
EPS next Year (2026-12-31): EPS=3.96 | Chg30d=+0.012 | Revisions Net=+1 | Growth EPS=+14.0% | Growth Revenue=+3.9%
Additional Sources for FLS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle